You may also need to figure out some dosages on your own, especially if your needs change. To keep your blood sugar in a safe range, you may take long-acting insulin, short-acting insulin ...

Your doctor may determine your dosage of Humulin R using a sliding ... Humulin R is a short-acting insulin, while Humulin N is an intermediate-acting insulin. This means they work over different ...

Let's start off slow. Long-acting insulin typically delivers a steady dose throughout the day and can last up to 24 hours. Intermediate-acting insulin can usually cover a time frame between 18 and ...

Along with these mealtime rapid-acting doses, people may also take a long-acting insulin dose once or twice per day. The aim of this is to set a stable baseline blood sugar level for the body to ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

In addition, if nocturnal hypoglycemia occurs after evening or bedtime administration of insulin glargine, either the dose should be ... A combination of long-acting insulin once a day and ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.